National Guideline Clearinghouse | Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy.
July 15, 2013
Guideline Title
Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy.
Bibliographic Source(s)
| National Institute for Health and Clinical Excellence (NICE). Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy. London (UK): National Institute for Health and Clinical Excellence (NICE); 2013 Jan. 52 p. (Technology appraisal guidance; no. 271). |
Guideline Status
This is the current release of the guideline.
No hay comentarios:
Publicar un comentario